A weak trend to the increment of Dex-CD86 occurred in patients with stable disease, while those in clinical progression showed low levels in all instances.
← all excerpts
Dendritic cell-derived exosomes (Dex) are potential biomarkers of response to Ipilimumab in metastatic melanoma
1
—
—